Management of Superficial Thrombophlebitis

Principal Investigator: Suman Rathbun, MD

Objective: 

Test the hypothesis that Fragmin (dalteparin sodium) 200 units/kg subcutaneously given at the time of presentation followed by 10,000 units given subcutaneously once daily for 6 days is more effective that Ibuprofen 800mg given orally three times daily for 7 days for the treatment of superficial thrombophlebitis.

Specific Aims:

1.  To evaluate the incidence of extension of superficial thrombophlebitis by ultrasound imaging in patients treated with dalteparin 200 units/kg at presentation followed by 10,000 units subcutaneously (sc) once daily or Ibuprofen 800mg orally three times daily.

2.  To evaluate the degree of pain resolution while taking the prescribed medication.

3.  To evaluate the risk of bleeding associated with the treatments.

4.  To gather descriptive/demographic data on patients with superficial thrombophlebitis.

5.  To perform a pharmacoeconomic assessment of treatment of superficial thrombophlebitis using low molecular weight heparin (Fragmin) versus oral ibuprofen.

Participant inclusion Criteria:

1. Patient with diagnosis of superficial thrombophlebitis

Particiapnt Compensation:

Contact:

Penny Razo-Mosier, LPN. (405) 271-4742  email penny-razo-mosier@ouhsc.edu

The University of Oklahoma Health Sciences Center
OUHSC HOME / SEARCH

General Clinical Research Center
O'Donoghue Research Building Suite 150
1122 N.E. 13th St. 
Oklahoma City, Oklahoma 73104
Phone: (405)271-4272

E-mail: julie-traylor@ouhsc.edu


This web site Built and Maintained by the Information Design Group a department of the University of Oklahoma Health Sciences Center.

Every effort will be made to update the information contained on these pages as necessary. However, it is the responsibility of the user to determine that he or she is relying on the most current version of any particular information. Any questions about the material should be directed to the referenced office or department.